A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults

Clinical trial NCT04533399 · COMPLETED

Trial details

NCT number: NCT04533399
Sponsor: Novavax
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

SARS-CoV-2 Infection COVID-19

Start date: 2020-08-17
Primary completion: 2021-12-07
Enrollment: 4422

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.